Cargando…

Adherence to AHA Guidelines When Adapted for Augmented Reality Glasses for Assisted Pediatric Cardiopulmonary Resuscitation: A Randomized Controlled Trial

BACKGROUND: The American Heart Association (AHA) guidelines for cardiopulmonary resuscitation (CPR) are nowadays recognized as the world’s most authoritative resuscitation guidelines. Adherence to these guidelines optimizes the management of critically ill patients and increases their chances of sur...

Descripción completa

Detalles Bibliográficos
Autores principales: Siebert, Johan N, Ehrler, Frederic, Gervaix, Alain, Haddad, Kevin, Lacroix, Laurence, Schrurs, Philippe, Sahin, Ayhan, Lovis, Christian, Manzano, Sergio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5468544/
https://www.ncbi.nlm.nih.gov/pubmed/28554878
http://dx.doi.org/10.2196/jmir.7379
_version_ 1783243455701450752
author Siebert, Johan N
Ehrler, Frederic
Gervaix, Alain
Haddad, Kevin
Lacroix, Laurence
Schrurs, Philippe
Sahin, Ayhan
Lovis, Christian
Manzano, Sergio
author_facet Siebert, Johan N
Ehrler, Frederic
Gervaix, Alain
Haddad, Kevin
Lacroix, Laurence
Schrurs, Philippe
Sahin, Ayhan
Lovis, Christian
Manzano, Sergio
author_sort Siebert, Johan N
collection PubMed
description BACKGROUND: The American Heart Association (AHA) guidelines for cardiopulmonary resuscitation (CPR) are nowadays recognized as the world’s most authoritative resuscitation guidelines. Adherence to these guidelines optimizes the management of critically ill patients and increases their chances of survival after cardiac arrest. Despite their availability, suboptimal quality of CPR is still common. Currently, the median hospital survival rate after pediatric in-hospital cardiac arrest is 36%, whereas it falls below 10% for out-of-hospital cardiac arrest. Among emerging information technologies and devices able to support caregivers during resuscitation and increase adherence to AHA guidelines, augmented reality (AR) glasses have not yet been assessed. In order to assess their potential, we adapted AHA Pediatric Advanced Life Support (PALS) guidelines for AR glasses. OBJECTIVE: The study aimed to determine whether adapting AHA guidelines for AR glasses increased adherence by reducing deviation and time to initiation of critical life-saving maneuvers during pediatric CPR when compared with the use of PALS pocket reference cards. METHODS: We conducted a randomized controlled trial with two parallel groups of voluntary pediatric residents, comparing AR glasses to PALS pocket reference cards during a simulation-based pediatric cardiac arrest scenario—pulseless ventricular tachycardia (pVT). The primary outcome was the elapsed time in seconds in each allocation group, from onset of pVT to the first defibrillation attempt. Secondary outcomes were time elapsed to (1) initiation of chest compression, (2) subsequent defibrillation attempts, and (3) administration of drugs, as well as the time intervals between defibrillation attempts and drug doses, shock doses, and number of shocks. All these outcomes were assessed for deviation from AHA guidelines. RESULTS: Twenty residents were randomized into 2 groups. Time to first defibrillation attempt (mean: 146 s) and adherence to AHA guidelines in terms of time to other critical resuscitation endpoints and drug dose delivery were not improved using AR glasses. However, errors and deviations were significantly reduced in terms of defibrillation doses when compared with the use of the PALS pocket reference cards. In a total of 40 defibrillation attempts, residents not wearing AR glasses used wrong doses in 65% (26/40) of cases, including 21 shock overdoses >100 J, for a cumulative defibrillation dose of 18.7 Joules per kg. These errors were reduced by 53% (21/40, P<.001) and cumulative defibrillation dose by 37% (5.14/14, P=.001) with AR glasses. CONCLUSIONS: AR glasses did not decrease time to first defibrillation attempt and other critical resuscitation endpoints when compared with PALS pocket cards. However, they improved adherence and performance among residents in terms of administering the defibrillation doses set by AHA.
format Online
Article
Text
id pubmed-5468544
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-54685442017-06-19 Adherence to AHA Guidelines When Adapted for Augmented Reality Glasses for Assisted Pediatric Cardiopulmonary Resuscitation: A Randomized Controlled Trial Siebert, Johan N Ehrler, Frederic Gervaix, Alain Haddad, Kevin Lacroix, Laurence Schrurs, Philippe Sahin, Ayhan Lovis, Christian Manzano, Sergio J Med Internet Res Original Paper BACKGROUND: The American Heart Association (AHA) guidelines for cardiopulmonary resuscitation (CPR) are nowadays recognized as the world’s most authoritative resuscitation guidelines. Adherence to these guidelines optimizes the management of critically ill patients and increases their chances of survival after cardiac arrest. Despite their availability, suboptimal quality of CPR is still common. Currently, the median hospital survival rate after pediatric in-hospital cardiac arrest is 36%, whereas it falls below 10% for out-of-hospital cardiac arrest. Among emerging information technologies and devices able to support caregivers during resuscitation and increase adherence to AHA guidelines, augmented reality (AR) glasses have not yet been assessed. In order to assess their potential, we adapted AHA Pediatric Advanced Life Support (PALS) guidelines for AR glasses. OBJECTIVE: The study aimed to determine whether adapting AHA guidelines for AR glasses increased adherence by reducing deviation and time to initiation of critical life-saving maneuvers during pediatric CPR when compared with the use of PALS pocket reference cards. METHODS: We conducted a randomized controlled trial with two parallel groups of voluntary pediatric residents, comparing AR glasses to PALS pocket reference cards during a simulation-based pediatric cardiac arrest scenario—pulseless ventricular tachycardia (pVT). The primary outcome was the elapsed time in seconds in each allocation group, from onset of pVT to the first defibrillation attempt. Secondary outcomes were time elapsed to (1) initiation of chest compression, (2) subsequent defibrillation attempts, and (3) administration of drugs, as well as the time intervals between defibrillation attempts and drug doses, shock doses, and number of shocks. All these outcomes were assessed for deviation from AHA guidelines. RESULTS: Twenty residents were randomized into 2 groups. Time to first defibrillation attempt (mean: 146 s) and adherence to AHA guidelines in terms of time to other critical resuscitation endpoints and drug dose delivery were not improved using AR glasses. However, errors and deviations were significantly reduced in terms of defibrillation doses when compared with the use of the PALS pocket reference cards. In a total of 40 defibrillation attempts, residents not wearing AR glasses used wrong doses in 65% (26/40) of cases, including 21 shock overdoses >100 J, for a cumulative defibrillation dose of 18.7 Joules per kg. These errors were reduced by 53% (21/40, P<.001) and cumulative defibrillation dose by 37% (5.14/14, P=.001) with AR glasses. CONCLUSIONS: AR glasses did not decrease time to first defibrillation attempt and other critical resuscitation endpoints when compared with PALS pocket cards. However, they improved adherence and performance among residents in terms of administering the defibrillation doses set by AHA. JMIR Publications 2017-05-29 /pmc/articles/PMC5468544/ /pubmed/28554878 http://dx.doi.org/10.2196/jmir.7379 Text en ©Johan N Siebert, Frederic Ehrler, Alain Gervaix, Kevin Haddad, Laurence Lacroix, Philippe Schrurs, Ayhan Sahin, Christian Lovis, Sergio Manzano. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 29.05.2017. http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research, is properly cited. The complete bibliographic information, a link to the original publication on http://www.jmir.org/, as well as this copyright and license information must be included.
spellingShingle Original Paper
Siebert, Johan N
Ehrler, Frederic
Gervaix, Alain
Haddad, Kevin
Lacroix, Laurence
Schrurs, Philippe
Sahin, Ayhan
Lovis, Christian
Manzano, Sergio
Adherence to AHA Guidelines When Adapted for Augmented Reality Glasses for Assisted Pediatric Cardiopulmonary Resuscitation: A Randomized Controlled Trial
title Adherence to AHA Guidelines When Adapted for Augmented Reality Glasses for Assisted Pediatric Cardiopulmonary Resuscitation: A Randomized Controlled Trial
title_full Adherence to AHA Guidelines When Adapted for Augmented Reality Glasses for Assisted Pediatric Cardiopulmonary Resuscitation: A Randomized Controlled Trial
title_fullStr Adherence to AHA Guidelines When Adapted for Augmented Reality Glasses for Assisted Pediatric Cardiopulmonary Resuscitation: A Randomized Controlled Trial
title_full_unstemmed Adherence to AHA Guidelines When Adapted for Augmented Reality Glasses for Assisted Pediatric Cardiopulmonary Resuscitation: A Randomized Controlled Trial
title_short Adherence to AHA Guidelines When Adapted for Augmented Reality Glasses for Assisted Pediatric Cardiopulmonary Resuscitation: A Randomized Controlled Trial
title_sort adherence to aha guidelines when adapted for augmented reality glasses for assisted pediatric cardiopulmonary resuscitation: a randomized controlled trial
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5468544/
https://www.ncbi.nlm.nih.gov/pubmed/28554878
http://dx.doi.org/10.2196/jmir.7379
work_keys_str_mv AT siebertjohann adherencetoahaguidelineswhenadaptedforaugmentedrealityglassesforassistedpediatriccardiopulmonaryresuscitationarandomizedcontrolledtrial
AT ehrlerfrederic adherencetoahaguidelineswhenadaptedforaugmentedrealityglassesforassistedpediatriccardiopulmonaryresuscitationarandomizedcontrolledtrial
AT gervaixalain adherencetoahaguidelineswhenadaptedforaugmentedrealityglassesforassistedpediatriccardiopulmonaryresuscitationarandomizedcontrolledtrial
AT haddadkevin adherencetoahaguidelineswhenadaptedforaugmentedrealityglassesforassistedpediatriccardiopulmonaryresuscitationarandomizedcontrolledtrial
AT lacroixlaurence adherencetoahaguidelineswhenadaptedforaugmentedrealityglassesforassistedpediatriccardiopulmonaryresuscitationarandomizedcontrolledtrial
AT schrursphilippe adherencetoahaguidelineswhenadaptedforaugmentedrealityglassesforassistedpediatriccardiopulmonaryresuscitationarandomizedcontrolledtrial
AT sahinayhan adherencetoahaguidelineswhenadaptedforaugmentedrealityglassesforassistedpediatriccardiopulmonaryresuscitationarandomizedcontrolledtrial
AT lovischristian adherencetoahaguidelineswhenadaptedforaugmentedrealityglassesforassistedpediatriccardiopulmonaryresuscitationarandomizedcontrolledtrial
AT manzanosergio adherencetoahaguidelineswhenadaptedforaugmentedrealityglassesforassistedpediatriccardiopulmonaryresuscitationarandomizedcontrolledtrial